Augenzentrum Erzgebirge
- Address
- Thumer Str. 14, 09405 Zschopau, Germany
Augenzentrum Erzgebirge - Retinal Vascular Disease Research
Augenzentrum Erzgebirge is a specialized ophthalmology research center with expertise in retinal vascular disorders and advanced treatment strategies. The center focuses on optimizing therapeutic approaches for vision-threatening conditions affecting the retina, particularly investigating innovative combinations of medical and laser-based interventions.
- Central retinal vein occlusion and associated macular edema
- Intravitreal anti-VEGF therapy optimization with ranibizumab
- Peripheral laser photocoagulation techniques for retinal vascular disease
The center's research emphasizes long-term treatment outcomes and strategies to reduce the burden of chronic therapy in patients with retinal vein occlusion. Through guideline-conform protocols, investigators examine whether combining early targeted peripheral laser photocoagulation with standard ranibizumab injections can shorten treatment duration or even allow successful therapy termination, potentially improving quality of life while maintaining visual outcomes for patients with macular edema secondary to central retinal vein occlusion.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Augenzentrum Erzgebirge
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Ranibizumab with or without Early Targeted Peripheral Laser Photocoagulation in Macular Edema Secondary to Central Retinal Vein Occlusion | Justus-Liebig-Universitaet Giessen | Phase III | Not Recruiting | Aug 2020 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ranibizumab | 1 | Unknown | 2020-08-17 | 2020-08-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.